SAN FRANCISCO — When the San Francisco Giants closed the book on an offseason that lacked fireworks, critics were quick to point out what the front office did not do. There was no headline-grabbing closer signed to a nine-figure deal. No blockbuster trade to silence concerns about a bullpen that unraveled at key moments last season. Instead, there was a quiet Thanksgiving move that barely rippled across the league: a one-year contract for left-handed reliever Sam Hentges.

At the time, it looked like depth. Now, it might look like foresight.

Hentges arrives in San Francisco carrying both promise and question marks. The 29-year-old did not throw a single pitch in 2025 for the Cleveland Guardians after a frustrating chain of injuries derailed what had once been a steady upward trajectory. A shoulder issue cut short his 2024 campaign, and as he worked his way back, a knee procedure in 2025 sidelined him for months. In November, Cleveland opted not to tender him a contract.

That decision opened a door. The Giants stepped through it.

If health cooperates, the numbers suggest San Francisco may have uncovered something far more valuable than a low-risk flyer. From 2022 through 2024, Hentges quietly evolved into one of the more effective left-handed relievers in the American League. In 2022, he posted a sparkling 2.32 ERA across 62 innings, demonstrating swing-and-miss stuff paired with a heavy fastball that generated uncomfortable at-bats. In 2023, he followed with a 3.61 ERA in 56 appearances, maintaining durability and reliability. Even in 2024, before the shoulder injury shut him down, he logged a 3.04 ERA in 26 outings, flashing the same poise in high-leverage situations.

For a Giants bullpen that remains largely undefined, that résumé is not insignificant.

President of baseball operations Buster Posey has been candid this spring: competition will determine roles. There are no guaranteed innings beyond the obvious late-game anchors. It is an open audition, and in that environment, upside becomes currency. Hentges, if fully healthy, brings both experience and deception from the left side — a profile that tends to age well and translate across ballparks.

The expectation inside camp is that he will be ready for full participation in spring training games, a crucial checkpoint after consecutive injury-marred seasons. For pitchers, health is not simply about velocity readings on a radar gun. It is about command repetition, recovery between outings, and the confidence to attack hitters without hesitation. Those are elements Hentges must reestablish quickly.

There is, naturally, skepticism. Shoulder injuries are not minor inconveniences, and a subsequent knee procedure raises additional durability concerns. Rust is inevitable. Timing may waver. Command could drift in early appearances. But relief pitching, perhaps more than any other role in baseball, can pivot dramatically with one strong month. If Hentges strings together clean innings in March and April, perception will shift just as quickly as it formed.

At present, left-hander Erik Miller projects as the Giants’ primary option in high-leverage spots. Yet bullpens rarely adhere to preseason blueprints. Roles evolve. Injuries intervene. Momentum reshapes hierarchies. It would not be surprising if, by midseason, Hentges is entrusted with key late-inning matchups against the heart of opposing lineups. His combination of size, angle, and previous success against both right- and left-handed hitters gives manager and staff flexibility — a prized asset over a 162-game grind.

There is also a strategic component to this signing that should not be overlooked. By avoiding splashy commitments, the Giants preserved financial and roster flexibility while taking calculated chances on rebound candidates. If even one of those bets pays off, the return on investment could be significant. In Hentges’ case, the ceiling is a reliable late-inning arm acquired at a fraction of the cost of marquee names.

The broader question hovering over San Francisco is whether this understated winter will age better than flashier ones elsewhere. The bullpen, labeled a “major question mark” by many analysts, could become a quiet strength if internal competition sharpens performance. Hentges embodies that possibility. He is not the headline. He is the subplot that could unexpectedly drive the story.

For now, all eyes turn to spring training box scores and radar readings. Each clean inning will chip away at doubt. Each setback will amplify it. But in a season where margins in the National League could prove razor thin, discovering hidden value may be the difference between October relevance and early disappointment.

The Giants did not dominate the offseason news cycle. They did not chase applause. Instead, they placed a measured wager on health, history, and projection. If Sam Hentges returns to his 2022-2024 form, that wager may soon be reframed not as a gamble, but as the quiet masterstroke that stabilized an entire bullpen — and perhaps, reshaped a season.